Point mutations in somatic cells play a role in the etiology of several classes of human pathologies. Experimental procedures are required that allow the detection and quantitation of such mutations in disease-related genes in tissue biopsy samples without the need for the selection of mutated cells. We describe the genotypic analysis of single base pair mutations in the Taq I endonuclease recognition sequence TCGA, residues 2508-2511 of exon 2 of the human c-H-rasi gene, by the restriction fragment length polymorphism/polymerase chain reaction (RFLP/PCR) approach. The high thermostability of Taq I endonuclease allows the continuous removal of eventual residual wild-type sequences during the thermocycling ofthe PCR and reduces polymerase errors in the finalRFLP/PCR product to a minimum. As few as five copies of a mutant standard containing two base pair changes in the chosen Taq I site could be rescued from 10" copies of wild-type DNA. Taq I RFLP/PCR holds promise for the monitoring of mutations in biochemical epidemiology.
Most presently available mammalian mutation systems rely on the isolation of a small fraction of mutated cells with a selectable mutated phenotype. Only mutations in a few genes can be analyzed by this approach, and growing cell cultures have to be used for the ex vivo or in vitro expansion of mutated cells. Methods are required for the analysis of mutations in disease-related genes and in sequences that are known or suspected to contain mutational hot-spots. Furthermore, mutation analysis should be possible in nondividing tissue biopsy samples. To avoid phenotypic selection, rare mutated DNA sequences have to be detectable in the presence of an enormous excess of homologous wild-type DNA, or they have to be separated by biochemical means. The sensitivity of recent experimental approaches to such "genotypic" mutation analysis (1, 2) is limited by backgrounds that originate from the large excess of wild-type DNA relative to mutated sequences. The restriction fragment length polymorphism/polymerase chain reaction (RFLP/ PCR) approach applied here, which measures mutations in restriction enzyme recognition sites, greatly reduces this problem (3, 4) . Wild-type recognition sites are cleaved by the corresponding endonuclease, allowing the selective amplification of mutated recognition sequences. The mixtures of amplified mutated fragments are either directly sequenced or cloned in AgtlO, and then plaques are analyzed by oligonucleotide hybridization.
We have chosen the Taq I restriction recognition sequence TCGA for RFLP/PCR mutation analysis for several reasons. Since the Taq I recognition sequence contains the four base pairs, it allows the analysis of all 12 possible single base pair mutations. In addition it contains the CpG dinucleotide sequence. Deamination of cytosine or 5-methylcytosine in CpG dinucleotides appears to represent a major mechanism for the formation of C --T transitions (5) (6) (7) (8) in genes related to genetic disease and cancer. The present Taq I RFLP/PCR protocol allows the rescue of as few as 5 to 10 mutated copies of Taq I site 2508-2511 located in exon 2 of the human c-H-rasl protooncogene from 108 homologous wild-type sequences.
METHODS
Preparation of Authentic Mutants at Taq I Site 2508-2511 of c-H-rasl. All 12 possible single base pair mutations in the tetranucleotide TCGA of the Taq I recognition sequence (residues 2508-2511) of exon 2 of the human c-H-rasl gene were prepared by using synthetic oligonucleotides and a PCR protocol (see Fig. 1 for sequence information). Twelve different 20-mers corresponding to residues 2499-2518 that contained single base changes in the TCGA sequence were used as left-side amplimers. A common right-side amplimer corresponding to nucleotides 2542-2562 plus an 11-nucleotide tail containing an EcoRI recognition sequence was used in 12 PCRs with pSVneo-rasl (9, 10) as template. The amplification conditions were as described below. The 12 resulting 75-base-pair (bp) fragments were used as right-side amplimers in a second round of amplifications with a common left-side amplimer corresponding to residues 2401-2420 plus a 12-nucleotide tail containing an EcoRI recognition sequence. The resulting 185-bp fragments were inserted into Agtlo. All authentic mutant AgtlO constructs were plaque purified on Escherichia coli C600 Hfl.
A mutant standard with two base pair changes in the Taq I recognition sequence and two additional upstream mutations was prepared according to the same experimental design, using the 21-mer 5'-ITCCCiTACAACGI-GACCTCG-3' (residues 2498-2518 of c-H-rasl; positions of mutations underlined) as right-side amplimer and a 20-mer corresponding to residues 2373-2392 of c-H-rasl as left-side amplimer. The left-side amplimer contained a 12-nucleotide tail with an EcoRI recognition site. The amplification conditions were as described below. The resulting 157-bp fragment was used as left-side amplimer in a second amplification reaction with a right-side amplimer corresponding to residues 2591-2610 plus a 12-nucleotide tail with an EcoRI recognition site. The final 261-bp fragment was cloned in pSP64. This plasmid is referred to as "mutant standard" (pSP64-rasTaqISt). A corresponding wild-type plasmid (pSP64-ras) was constructed by an analogous protocol.
Taq I Restriction and Amplification Conditions. Known amounts of pSP64-rasTaqISt and pSP64-ras were first digested with EcoRI to release the 253-bp ras inserts and subsequently with Taq I endonuclease at 6 units/dul for 2 hr at 650C. From these stocks eight samples were prepared that Abbreviation: RFLP/PCR, restriction fragment length polymorphism/polymerase chain reaction.
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contained the numbers of mutant standard and wild-type ras copies indicated in Table 1 . The samples were prepared in a total volume of 25 Al of amplification buffer: 2.5 A.l containing the DNA, each "amplimer" (see Fig. 1 and below) at 3 puM, 1 mM each of dATP, dCTP, dGTP, and dTTP, 21% (vol/vol) dimethyl sulfoxide, 66.6 mM Tris-HCl at pH 8.8, 16.6 mM ammonium sulfate, 6.7 mM MgCI2, 10 mM 2-mercaptoethanol, 6.7 ,tM EDTA, and 1.5 units of Taq DNA polymerase (Cetus). Under these conditions Taq polymerase exhibits relatively high replication fidelity (11) . Taq polymerase was added to the tubes after an initial melting period of 3 min at 920C.
PCR cycles 1-15. Outer amplimers-i.e., left-side 20-mer 2373-2392 and right-side 20-mer 2591-2610-were used (see Fig. 1 ). Each cycle consisted of a melting temperature of 810C (1.1 min), an annealing temperature of 550C (0.8 min), and an extension temperature of 65°C (0.3 min). To restrict eventual residual wild-type sequences, Taq I endonuclease (1.2 units) was added during the annealing periods of cycles 1, 3, 5, 7, 9, 11, 13, and 15.
PCR cycles [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . After the 15th cycle, the dimethyl sulfoxide concentration was reduced to 12% by the addition of dimethyl sulfoxide-free amplification mixture. The 16th cycle was begun with an initial melting period of 3 min at 920C, after which 1.5 units of Taq polymerase was added to each tube. Each cycle consisted of a melting temperature of 91°C (0.8 min) and an annealing temperature of 570C (0.4 min). After 25 cycles 4 units of Taq I endonuclease was added to each tube, and the mixtures were incubated for 30 min at 650C.
PCR cycles 25-50. After the 25th cycle 3-,l aliquots of the amplification mixtures were removed and diluted 121-fold. The amplification was continued under the conditions outlined above with a new, nested, pair of amplimers-i.e., left-side 20-mer 2401-2420 and right-side 21-mer 2542-2562 at 4 ,uM final concentrations. These amplimers contained in addition 5' tails with EcoRI recognition sequences to facilitate cloning in Agtl0 (see Fig. 1 ). After the 50th cycle 6 units of Taq I endonuclease was added and digestion was allowed to proceed for 1 hr at 650C.
Purification of Amplified DNA and Cloning in AgtlO. The amplification mixtures were purified on Qiagen-5 tips (Qiagen; Chatsworth, CA) and the DNA was precipitated with isopropyl alcohol after the addition of 1 ,ug of E. coli tRNA as carrier. DNA aliquots were ligated to AgtlO arms as outlined by the supplier (Promega). The phage DNA was packaged (Packagene, Promega) and used to infect E. coli C600 Hfl. Plaques were lifted onto colony/plaque screens (NEF-978, New England Nuclear). At least two independent packagings were carried out and 1-3 x 103 plaques on [10] [11] [12] [13] [14] [15] Petri dishes were analyzed for each experimental condition.
Oligonucleotide Plaque Hybridization. Specific probes were prepared according to standard conditions by end-labeling of oligonucleotide 20-mers (residues 2499-2518) corresponding to the wild-type sequence of c-H-rasl, mutant standard containing 4 (Fig. 1) . These plasmids were digested with EcoRI to release the ras inserts and then exhaustively digested with Taq I endonuclease, and mixtures were prepared that contained 5, 10, 100, or 1000 copies of the mutant standard and 108 copies of the wild-type DNA (see Table 1 ). A 185-bp fragment containing the Taq site 2508-2511 was amplified by PCR. Conditions were chosen for the first 15 PCR cycles that allowed the continuous Taq I endonuclease restriction of eventual residual wild-type sequences (see Fig. 1 
.8% of the identified A plaques. The fraction of identified plaques containing the mutant standard sequence increased with increasing input copy number and was 8.5 ± 2.6 for 10 initial copies, 43.8 ± 7.0 for 100 initial copies, and 80.3 ± 18.2 for 1000 initial copies (Fig. 2) . The total fractions of plaques that could be identified with the 14 oligonucleotide probes varied from 63% to 74%, leaving approximately 1/3 of the plaques unidentified. Direct sequencing of DNA from several plaques by primer extension (see below) indicated that they contained amplimer multimers, small deletions and insertions affecting the Taq I site 2508-2511, and also single base pair changes in this site that had escaped detection by oligonucleotide hybridization.
Since the mutant standard contains two additional mutated sites upstream, single base pair mutations in the selected Taq I site do not affect the frequency of mutant standard plaques detected by oligonucleotide hybridization. In contrast, the sensitivity with which a particular base pair change can be detected in the Taq I site 2508-2511 depends on the frequency with which this particular mutation is produced by polymerase infidelity on residual unrestricted wild-type templates. As shown in Fig. 2 RFLP/PCR protocol except for transitions involving A-T base pairs, which represent frequent Taq polymerase errors. Sequence Analysis of Taq I RFLP/PCR Products by Primer Extension. The Taq I RFLP/PCR products were subjected to direct sequencing by the extension of a 21-mer (corresponding to residues 2441-2461). Fig. 3 gives the results for wild-type DNA, for the RFLP/PCR product from the initial mixture containing 103 copies of Taq I mutant standard, and for authentic Taq I mutant standard DNA. The presence of the mutant standard in the RFLP/PCR product is readily discernible in the sequence shown in the center of Fig. 3 , where bands for residues T2498, G2503, A2508, and T2511 are visible that are absent from the wild-type sequence shown to the left. The four lanes of the autoradiograms for each sequence were scanned with a densitometer. The tracings are shown in Fig. 4 for the RFLP/PCR product of the initial mixture containing 103 copies of mutant standard and 108 copies of wild-type sequence. Peaks are discernible for the residues indicated above that are specific for the mutant standard sequence.
Band intensities for individual residues vary for sequences of unique DNA Fig. 3 ). The peaks originating from residues specific for mutant standard and the positions of wild-type residues that served for data normalization are indicated. RFLP/PCR product originating from initially 5 copies of mutant standard and 108 copies of wild-type DNA (data not shown). We conclude that direct sequencing by primer extension of the Taq I RFLP/PCR products allows the detection of the more abundant mutations. DISCUSSION The RFLP/PCR protocol for analysis of genotypic mutations measures mutations in restriction enzyme recognition sequences. This allows the efficient enrichment of mutated over wild-type sequences by exhaustive restriction with the corresponding endonuclease followed by the selective amplification of the uncut sequences by PCR. We had explored the feasibility of this approach in studies of Pvu II site 1727-1732 and Msp I site 1695-1698 of exon 1 of the human c-H-rasl gene. As few as 10 copies of Pvu II mutant standard with two base pair changes in the recognition sequence and a third mutation upstream of the site could be rescued by the RFLP/PCR procedure from 108-109 wild-type sequences (3, 4) .
The Taq I RFLP/PCR protocol described here allowed the efficient rescue of mutant standard that contains two base pair replacements in the Taq I site 2508-2511 and two additional changes 5' upstream of this site from a large excess of wild-type DNA. Plaque hybridization as well as sequencing allowed the determination of the mutant standard content of RFLP/PCR mixtures originating from the initial mixtures of only 5 copies of mutant standard and 108 copies of wild-type DNA. Highest reproducibility was observed for the content of G2503, which is specific for the mutant standard, and the corresponding wild-type residue, C2503, by direct sequencing (see Table 1 ). Residue 2503 is located 5' upstream of the Taq I site 2508-2511 and mutations at this residue are not selected. Therefore, sequences containing wild-type C2503 must be mutated in Taq I site 2508-2511.
The capacity of the RFLP/PCR protocol to rescue single base pair mutations is limited by the amount of residual unrestricted wild-type DNA that is present during PCR because of the limited fidelity of the polymerase, in particular of Taq polymerase, used in the reaction (4, (10) (11) (12) (13) Taq I RFLP/PCR product contained the wild-type sequence. In contrast, the percentages of wild-type plaques in the Pvu II site 1727-1732 and in the Msp I site 1695-1698 RFLP/PCR products of the c-H-rasl gene were in the range of 14-23% and 35-40%, respectively (4) .
Even in the Taq I RFLP/PCR system a few copies of uncut wild-type DNA remain, and mutations are produced experimentally due to Taq polymerase infidelity. By far the most frequent Taq polymerase error according to plaque hybridization was A-T 2511 -G-C (TCG.Q), followed by T-A 2508 -* A-T (ACGA). This agrees with published work, in which A-T -+ G-C transitions were reported to be the most frequent Taq polymerase errors (11) (12) (13) (14) . However, RFLP/PCR analysis of two independent restriction sites in exon 1 ofc-H-rasl revealed different spectra of Taq polymerase errors. The predominant Taq mutations in the internal tetranucleotide of Pvu II site 1727-1732 were C-G 1730 -+ G-C (AGGT) and, at lower frequency, C-G 1730 --A'T (AGAT), while the predominant Taq mutations at the two G residues of Msp I site 1695-1698 were G-C 1698 --T-A (CCGT) and, at lower frequency, G-C 1698 --AT (CCGA) (4). It appears that Taq polymerase fidelity depends more on sequence context than on the base pair that is being replicated. The mutant standard content of the RFLP/PCR product originating from a known number of initial copies allows an estimate of the sensitivity of the Taq I RFLP/PCR protocol for specific base pair changes. For some mutations with low Taq polymerase backgrounds-e.g., T-A 2508 -* G'C (QCGA) and G-C 2510 -* C'G (TCCA) (see Fig. 2 (4) .
The sensitivity of mutant quantitation in the RFLP/PCR product by cloning and plaque hybridization is high, but the procedure is laborious and costly. The data in Table 1 indicate that quantitative sequence analysis was capable of measuring single base pair mutations in the Taq I site 2508-2511 originating from minimally 10-100 initial copies of mutant standard plus 108 copies of wild-type DNA. Modification ofthe PCR conditions and the use of polymerases with lower error rates (14) might further increase the overall sensitivity of RFLP/PCR mutation analysis and allow its application to the measurement of spontaneous and xenobiotic-induced somatic mutations in disease related genes in humans (15) (16) (17) (18) (19) .
